Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-25-000012

Chief Executive Officer bought 15,000 shares at $0.91 ($13,641)

From the SEC's structured data for this filing

Trades in this filing

CHRISTOPHER RICHARD · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-07-29 Purchase : show line 1 in the form +15,000 $0.91 $13,641 65,000 D
Open-market purchases · 15,000 sh · avg $0.91 · $13,641
Loading xslF345X05/primary_doc.xml…